Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model

Manoj Amrutkar, Emmelie Cansby, Urszula Chursa, Esther Nuñez-Durán, Belén Chanclón, Marcus Ståhlman, Vincent Fridén, Louise Mannerås-Holm, Anna Wickman, Ulf Smith, Gert Fredrik Bäckhed, Jan Borén, Brian W Howell, Margit Mahlapuu

    30 Citationer (Scopus)
    Plum Print visual indicator of research metrics
    • Citations
      • Citation Indexes: 51
    • Captures
      • Readers: 38
    see details

    Abstract

    Understanding the molecular networks controlling ectopic lipid deposition, glucose tolerance, and insulin sensitivity is essential to identifying new pharmacological approaches to treat type 2 diabetes. We recently identified serine/threonine protein kinase 25 (STK25) as a negative regulator of glucose and insulin homeostasis based on observations in myoblasts with acute depletion of STK25 and in STK25-overexpressing transgenic mice. Here, we challenged Stk25 knockout mice and wild- Type littermates with a high-fat diet and showed that STK25 deficiency suppressed development of hyperglycemia and hyperinsulinemia, improved systemic glucose tolerance, reduced hepatic gluconeogenesis, and increased insulin sensitivity. Stk252/2 mice were protected from diet-induced liver steatosis accompanied by decreased protein levels of acetyl-CoA carboxylase, a key regulator of both lipid oxidation and synthesis. Lipid accumulation in Stk252/2 skeletal muscle was reduced, and expression of enzymes controlling the muscle oxidative capacity (Cpt1, Acox1, Cs, Cycs, Ucp3) and glucose metabolism (Glut1, Glut4, Hk2) was increased. These data are consistent with our previous study of STK25 knockdown in myoblasts and reciprocal to the metabolic phenotype of Stk25 transgenic mice, reinforcing the validity of the results. The findings suggest that STK25 deficiency protects against the metabolic consequences of chronic exposure to dietary lipids and highlight the potential of STK25 antagonists for the treatment of type 2 diabetes.

    OriginalsprogEngelsk
    TidsskriftDiabetes
    Vol/bind64
    Udgave nummer8
    Sider (fra-til)2791-804
    Antal sider14
    ISSN0012-1797
    DOI
    StatusUdgivet - aug. 2015

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model'. Sammen danner de et unikt fingeraftryk.

    Citationsformater

    Amrutkar, M., Cansby, E., Chursa, U., Nuñez-Durán, E., Chanclón, B., Ståhlman, M., Fridén, V., Mannerås-Holm, L., Wickman, A., Smith, U., Bäckhed, G. F., Borén, J., Howell, B. W., & Mahlapuu, M. (2015). Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model. Diabetes, 64(8), 2791-804. https://doi.org/10.2337/db15-0060